These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 15640610

  • 21. Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis.
    Rangel EB, Espósito BP, Carneiro FD, Mallet AC, Matos AC, Andreoli MC, Guimarães-Souza NK, Santos BF.
    Ther Apher Dial; 2010 Apr; 14(2):186-92. PubMed ID: 20438541
    [Abstract] [Full Text] [Related]

  • 22. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease.
    Agarwal R, Vasavada N, Sachs NG, Chase S.
    Kidney Int; 2004 Jun; 65(6):2279-89. PubMed ID: 15149341
    [Abstract] [Full Text] [Related]

  • 23. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 24. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G, Gârneata L, Capusa C, Ursea N.
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin.
    Aggarwal HK, Nand N, Singh S, Singh M, Hemant, Kaushik G.
    J Assoc Physicians India; 2003 Feb; 51():170-4. PubMed ID: 12725261
    [Abstract] [Full Text] [Related]

  • 31. 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.
    Tarng DC, Huang TP, Wei YH, Liu TY, Chen HW, Wen Chen T, Yang WC.
    Am J Kidney Dis; 2000 Nov; 36(5):934-44. PubMed ID: 11054349
    [Abstract] [Full Text] [Related]

  • 32. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin.
    Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G.
    Kidney Int; 2003 Aug; 64(2):572-8. PubMed ID: 12846752
    [Abstract] [Full Text] [Related]

  • 33. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF, Ding F, Zhu QY, Xue J, Lu FM, Gu Y, Lin ST.
    Ren Fail; 2005 Aug; 27(2):213-9. PubMed ID: 15807188
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
    Saglam F, Cavdar C, Uysal S, Cavdar Z, Camsari T.
    Ren Fail; 2007 Aug; 29(7):849-54. PubMed ID: 17994454
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Myocardial release of non-transferrin-bound iron during cardio-pulmonary bypass surgery.
    Ambrus CM, Lajos TZ, Stadler I, Stadler A, Alfano J, Tulumello JA, Ambrus JL.
    J Med; 1999 Aug; 30(3-4):157-67. PubMed ID: 17312669
    [Abstract] [Full Text] [Related]

  • 38. Impact of oral iron challenges on circulating non-transferrin-bound iron in healthy Guatemalan males.
    Schümann K, Kroll S, Romero-Abal ME, Georgiou NA, Marx JJ, Weiss G, Solomons NW.
    Ann Nutr Metab; 2012 Aug; 60(2):98-107. PubMed ID: 22398912
    [Abstract] [Full Text] [Related]

  • 39. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis.
    Rosenlöf K, Kivivuori SM, Grönhagen-Riska C, Teppo AM, Slimes MA.
    Clin Nephrol; 1995 Apr; 43(4):249-55. PubMed ID: 7606879
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.